Distinct clinical perspectives discerned in these studies coalesce under the theme of the loss of one allele of GATA2 resulting in the GATA2 haploinsufficiency syndrome, which can present with immunodeficiency, lymphedema and 80% predisposition to develop MDS/AML. The gene discussed is GATA2; the disease is immune system disorder.